Êtes-vous sûr(e) de vouloir fermer ?
Le fait de fermer ne sauvegardera pas votre configuration à moins que vous n'ajoutiez l'article à votre Panier d'achat ou à vos Favoris.
Cliquer sur OK pour fermer l'outil MILLIPLEX® MAP ou sur Annuler pour retourner à votre sélection.
Choisissez des Panels configurables & des Kits préconfigurés - OU - des MAPmate™ de signalisation cellulaire
Concevez vos kits MILLIPLEX® MAP et obtenez leur prix.
Panels configurables & Kits préconfigurés
Notre large gamme est constituée de panels multiplex qui vous permettent de choisir, au sein d'un panel, les analytes qui répondent le mieux à vos besoins. Sur un autre onglet, vous pouvez choisir un format cytokine préconfiguré ou un kit Simplex.
Kits de signalisation cellulaire & MAPmate™
Choisissez des kits préconfigurés qui permettent d'explorer l'ensemble des voies ou des processus. Ou concevez vos propres kits en choisissant des Simplex MAPmate™ et en suivant les instructions fournies.
Les MAPmate™ suivants ne peuvent pas être utilisés ensemble :
-des MAPmate™ qui nécessitent des tampons différents
-des paires de MAPmate™ totaux et phospho-spécifiques, par ex. GSK3β total et GSK3β (Ser 9)
-des MAPmate™ PanTyr et spécifiques d'un site, par ex. Récepteur Phospho-EGF et phospho-STAT1 (Tyr701)
-Plus d'un phospho-MAPmate™ pour une seule cible (Akt, STAT3).
-GAPDH et β-Tubuline ne peuvent pas être utilisés avec les kits ou les MAPmate™ contenant panTyr.
.
| Référence | Guide d'achat | Qté | Liste |
Cet article a été ajouté à vos favoris.
Sélectionner une espèce, un type de panel, un kit ou un type d'échantillon
Pour commencer à concevoir votre kit MILLIPLEX® MAP, sélectionnez une espèce, un type de panel ou un kit d'intérêt.
| Espèce |
Type de panel |
Kit sélectionné |
Type d'échantillon |
Modifier |
| Sélectionner une espèce | . |
| Sélectionner un type de panel | . |
| Sélectionner un kit | . |
| Sélectionner un type d'échantillon | Pour certains panels, le type d'échantillon déterminera les analytes qui peuvent être utilisés ensemble. |
Choisissez parmi les analytes de nos Panels Multiplex disponibles ou parmi nos Kits préconfigurés & Simplex
Concevez votre propre kit ou choisissez parmi nos Panels préconfigurés et Simplex.
Custom Premix
Selecting "Custom Premix" option means that all of the beads you have chosen will be premixed in manufacturing before the kit is sent to you.
Selecting "Custom Premix" option means that all of the beads you have chosen will be premixed in manufacturing before the kit is sent to you.
| Catalogue Number | Ordering Description | Qty/Pack | List |
Cet article a été ajouté à vos favoris.
| Espèce |
|
| Type de panel | |
| Kit sélectionné | |
| Qté | Référence | Guide d'achat | Qté | Prix tarif |
| 96-Well Plate |
| Qté | Référence | Guide d'achat | Qté | Prix tarif |
Ajouter des réactifs supplémentaires (Un kit "Buffer and Detection Kit" est nécessaire pour une utilisation avec les MAPmate™)
| Qté | Référence | Guide d'achat | Qté | Prix tarif |
| 48-602MAG | Buffer Detection Kit for Magnetic Beads | 1 Kit |
Option de gain de place
Nos clients qui commandent plusieurs kits peuvent choisir d'économiser de l'espace de stockage en éliminant l'emballage de chaque kit et de recevoir les composants de leur essai multiplex conditionnés sous poches en plastique pour un stockage plus compact.
Nos clients qui commandent plusieurs kits peuvent choisir d'économiser de l'espace de stockage en éliminant l'emballage de chaque kit et de recevoir les composants de leur essai multiplex conditionnés sous poches en plastique pour un stockage plus compact.
Cet article a été ajouté à vos favoris.
Ce produit a été ajouté à votre panier.
Vous pouvez maintenant concevoir un autre kit personnalisé, choisir un kit pré-configuré, régler vos achats ou fermer l'outil de commande.
Pharma and Biopharma Manufacturing Webinars
Browse Our On-Demand Webinars:
Register Today for Our Upcoming Webinars
Take part in our complimentary, live webinars, where you’ll interact with experts who are breaking ground in the pharmaceutical and biopharmaceautical industries. You’ll learn about the newest tools and technologies while gathering valuable tips and troubleshooting strategies for the applications most relevant to your processes.
Find an upcoming webinar below and register today!
Reducing Risk and Decreasing Timelines for Biopharmaceutical Cell Line Development Through Optimized Reagents and Processes
|
Abstract: Join us to learn about challenges faced with traditional expression systems and how a CHO cell line with the glutamine synthetase knock-out via ZFN provides benefits for fast, efficient cell line development with stable and high titer expression. CHO cells with their unique characteristics, represent the major expression system within the biopharmaceutical industry. However, one of the major challenges in cell line development is to identify those rare, high-producing clones in a huge population of non-expressing or low-expressing cell lines. This leads to laborious and time consuming cell line development processes. This webinar will educate the audience about challenges faced with traditional expression systems and how the CHO cell line with the glutamine synthetase knock-out via Zinc Finger Nucleases provides benefits for fast and efficient cell line development as well as stable and high titer expression. We will explore additional cell line engineering targets that can be modified to engineer a cell line that mitigates risks and removes bottlenecks throughout the biopharmaceutical process. In this webinar, you will learn:
|
A Molecule’s Journey – Breaking Down Roadblocks to Commercial Success
|
Abstract: Every biopharma executive must make important decisions early in clinical development that will impact their molecule’s journey – and ultimately the success of their commercial strategy. The key to this success is to make the right decisions at the right time. In this webinar, our experts share some key considerations to help biopharmaceutical companies successfully advance a molecule from the laboratory to the clinic as quickly as possible without sacrificing product quality, process efficiency, or patient safety. To achieve this goal, companies must navigate the complexities associated with business planning, cell line development, process development, technology, and regulatory and risk assessment. In this webinar, you will learn:
|
Comprehensive Assessment of a Stimulus-Responsive Flocculation Polymer for Cell Culture Clarification
|
Abstract: This webinar will provide a comprehensive, holistic assessment of the effects of Clarisolve® mPAA flocculation polymer pre-treatment upon clarification and subsequent downstream chromatography steps. Flocculation is a simple method to pre-clarify high density Chinese hamster ovary (CHO) cell culture feed streams, allowing for an efficient clarification process that would otherwise not be feasible using traditional depth filters. Clarisolve® mPAA polymer is a stimulus-responsive flocculation polymer that may provide a reduced dosing dependency and lower residual polymer levels when compared to other flocculants. Cell culture pre-treatment with Clarisolve® mPAA polymer followed by clarification using Clarisolve® 60HX depth filters, enables a significant increase of harvest throughputs and allows for a single clarification stage for these high-density feed streams. Furthermore, by eliminating the need for centrifugation, pre-treatment with Clarisolve® mPAA polymer allows for the implementation of a single-use clarification train.This webinar will review the efficacy of pretreatment with a range of Clarisolve® mPAA polymer concentrations upon the clarification and purification of a CHO cell culture feed stream. These results were compared to material prepared using conventional Millistak+® HC depth filtration media to deliver a comprehensive, holistic assessment of the effects of Clarisolve® mPAA polymer pre-treatment upon the clarification and subsequent downstream chromatography steps. In this webinar, you will learn more about:
|
Overview of the Regulatory Landscape for Plastic Devices in Pharmaceutical Manufacturing
|
Abstract: This webinar highlights regulations for plastic devices in pharmaceutical manufacturing, a risk-based approach to qualifying components, and the importance of regulatory documentation. The growing complexity of therapeutics and globalization are some of the factors leading to innovative manufacturing solutions. Thanks to their flexibility and ease of use, polymeric materials are being used more frequently in the manufacturing of pharmaceuticals and biopharmaceuticals. Consequently, the development and qualification of plastic components requires a purposeful implementation of a multifaceted regulatory guidance. However, the lack of regulations specific to plastics used in pharmaceutical manufacturing systems has led to considerable uncertainty. In this webinar, you will learn:
|
Identifying Appropriate-Quality Pharmaceutical Raw Materials in an Evolving Regulatory Environment
Session 1: 3:00 AM EST, 12 AM PST, 9 AM CET View your Time Zone start time
Register Now Session 2: 11:00 AM EST, 8 AM PST, 5 PM CET View your Time Zone start time
Register Now |
Abstract: This webinar will discuss appropriate quality attributes for different raw material uses, present strategies to support identification, selection and risk assessment of raw materials, and highlight the importance of regulatory documentation. Recent and continuing regulatory improvements require drug manufacturers to assess and mitigate risk throughout their entire processes. This includes raw materials used at every stage of manufacturing and clinical phases. Current regulatory guidelines and industry standards clearly define quality requirements for raw materials that are incorporated into, or used close to, final drug product, for example active ingredients and excipients. However, no such clear standards are defined for chemicals used earlier in the process, such as in upstream bioprocessing, early chemical synthesis stages, or clean-in-place. The absence of such standards presents a challenge to efficiently and effectively source raw materials with appropriate supply chain transparency and control, accompanied by the necessary supporting documentation. In this webinar, you will learn:
|